Bladder-sparing Therapy for Bacillus Calmette-Guérin–unresponsive Non–muscle-invasive Bladder Cancer: International Bladder Cancer Group Recommendations for Optimal Sequencing and Patient Selection
Journal
European Urology
ISSN
0302-2838
Date Issued
2024
Author(s)
Roger Li
Patrick J. Hensley
Shilpa Gupta
Hikmat Al-Ahmadie
Marko Babjuk
Peter C. Black
Maurizio Brausi
Kelly K. Bree
Charles C. Guo
Amir Horowitz
Donald L. Lamm
Seth P. Lerner
Yair Lotan
Paramananthan Mariappan
David McConkey
Laura S. Mertens
Carmen Mir
Jeffrey S. Ross
Michael O’Donnell
Joan Palou
Kamal Pohar
Gary Steinberg
Mark Soloway
Philippe E. Spiess
Robert S. Svatek
Wei Shen Tan
Rikiya Taoka
Roger Buckley
Ashish M. Kamat
Type
journal-article
Cite this document
Li, R., Hensley, P. J., Gupta, S., Al-Ahmadie, H., Babjuk, M., Black, P. C., Brausi, M., Bree, K. K., Fernández, M. I., Guo, C. C., Horowitz, A., Lamm, D. L., Lerner, S. P., Lotan, Y., Mariappan, P., McConkey, D., Mertens, L. S., Mir, C., Ross, J. S., … Kamat, A. M. (2024). Bladder-sparing therapy for bacillus calmette-guérin–unresponsive non–muscle-invasive bladder cancer: International bladder cancer group recommendations for optimal sequencing and patient selection. European Urology, S0302283824025168. https://doi.org/10.1016/j.eururo.2024.08.001